MGC Diagnostics Corporation
http://mgcdiagnostics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From MGC Diagnostics Corporation
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Khan Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.
Formycon’s Lucentis Biosimilar Enters Swiss and Canada Markets
Switzerland and Canada mark the first market entries for Formycon’s ranibizumab biosimilar this year, with several anticipated launches in the Middle East later in 2024.
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
FTC Sides With Amneal Over Inhaler Patent Dispute With Teva
After sending warning letters over more than 100 improper patent listings last year, the FTC has backed Amneal in its attempt to fight ProAir originator Teva over asthma inhalers.
Company Information
- Industry
-
Medical Devices
- Diagnostic Equipment & Supplies
- Other Names / Subsidiaries
-
- Angeion Corporation
- MGC Diagnostics Corporation (effective August 21, 2012)
- MediSoft SA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice